These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26878132)

  • 1. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
    Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
    Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
    Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
    J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.
    Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D
    Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.
    Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P
    Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
    Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
    Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
    Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
    Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
    Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
    J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification.
    Bougard D; Bélondrade M; Mayran C; Bruyère-Ostells L; Lehmann S; Fournier-Wirth C; Knight RS; Will RG; Green AJE
    Emerg Infect Dis; 2018 Jul; 24(7):1364-1366. PubMed ID: 29912702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel histotypes of sporadic Creutzfeldt-Jakob disease linked to 129MV genotype.
    Cracco L; Puoti G; Cornacchia A; Glisic K; Lee SK; Wang Z; Cohen ML; Appleby BS; Cali I
    Acta Neuropathol Commun; 2023 Aug; 11(1):141. PubMed ID: 37653534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.